Pharmanet Group

Pharmanet Group Limited engaged in the research, development, manufacture, and distribution of pharmaceutical products primarily in Australia. The company offered ThermaLIFE cream for use as a temporary relief from muscular skeletal and arthritic pain. It also holds patent application for the use and manufacture of an analgesic and anti-inflammatory composition; and three patent families directed for compositions having activities, such as treating tissue disruptions, mediating Cox-2 inhibition, and cytokine and secondary injury mediation. In 2017 the company was recapitalised through a Deed of Company Arrangement involving Otsana Capital and Discovery Capital Partners, and soon after the company announced a proposed acquisition of Keras Resources' Australian gold operationsin a reverse takeover deal to become Calidus Resources.